Anna Patten

2.9k total citations
78 papers, 2.2k citations indexed

About

Anna Patten is a scholar working on Pediatrics, Perinatology and Child Health, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Anna Patten has authored 78 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Pediatrics, Perinatology and Child Health, 53 papers in Psychiatry and Mental health and 32 papers in Cellular and Molecular Neuroscience. Recurrent topics in Anna Patten's work include Epilepsy research and treatment (52 papers), Pharmacological Effects and Toxicity Studies (43 papers) and Neuroscience and Neuropharmacology Research (29 papers). Anna Patten is often cited by papers focused on Epilepsy research and treatment (52 papers), Pharmacological Effects and Toxicity Studies (43 papers) and Neuroscience and Neuropharmacology Research (29 papers). Anna Patten collaborates with scholars based in United Kingdom, United States and Canada. Anna Patten's co-authors include Brian R. Christie, Joana Gil‐Mohapel, Patrícia S. Brocardo, Christine J. Fontaine, Antonio Laurenza, Luigi Giorgi, Helle M. Sickmann, Suk‐Yu Yau, Robert Wechsler and Gregory L. Krauss and has published in prestigious journals such as Neurology, The Lancet Neurology and Brain Research.

In The Last Decade

Anna Patten

74 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Patten United Kingdom 26 1.3k 923 767 305 243 78 2.2k
Don Shin United States 31 805 0.6× 1.3k 1.4× 1.7k 2.2× 278 0.9× 830 3.4× 52 2.8k
Gregory C. Mathews United States 15 318 0.2× 508 0.6× 1.0k 1.3× 144 0.5× 573 2.4× 18 1.6k
Anvita Kale India 22 577 0.4× 244 0.3× 263 0.3× 133 0.4× 299 1.2× 39 1.7k
Elsa M. Valdizán Spain 25 295 0.2× 474 0.5× 867 1.1× 114 0.4× 366 1.5× 57 1.8k
Maria José da Silva Fernandes Brazil 24 191 0.1× 479 0.5× 774 1.0× 106 0.3× 394 1.6× 51 1.5k
Vanya Stefovska Germany 15 1.4k 1.0× 279 0.3× 1.4k 1.9× 1.6k 5.2× 952 3.9× 19 3.9k
Robert F. Berman United States 28 429 0.3× 282 0.3× 972 1.3× 83 0.3× 400 1.6× 54 1.9k
Masahiko Ishimaru Japan 14 1.1k 0.8× 115 0.1× 756 1.0× 740 2.4× 548 2.3× 18 2.3k
John W. Dailey United States 28 464 0.3× 964 1.0× 1.6k 2.1× 49 0.2× 798 3.3× 50 2.3k
Tiffany J. Mellott United States 24 549 0.4× 109 0.1× 252 0.3× 130 0.4× 633 2.6× 36 1.7k

Countries citing papers authored by Anna Patten

Since Specialization
Citations

This map shows the geographic impact of Anna Patten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Patten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Patten more than expected).

Fields of papers citing papers by Anna Patten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Patten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Patten. The network helps show where Anna Patten may publish in the future.

Co-authorship network of co-authors of Anna Patten

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Patten. A scholar is included among the top collaborators of Anna Patten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Patten. Anna Patten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Porter, Brenda E., Ryutaro Kira, Jeehun Lee, et al.. (2023). Efficacy and safety of perampanel in a randomized, placebo-controlled trial with an open-label extension in patients with seizures associated with Lennox-Gastaut syndrome (LGS). Journal of the Neurological Sciences. 455. 121563–121563. 1 indexed citations
3.
Wechsler, Robert, James W. Wheless, Muhammad Zafar, et al.. (2021). PROVE: Retrospective, non‐interventional, Phase IV study of perampanel in real‐world clinical care of patients with epilepsy. Epilepsia Open. 7(2). 293–305. 18 indexed citations
4.
Kanner, Andrés M., Anna Patten, Alan B. Ettinger, et al.. (2021). Does a psychiatric history play a role in the development of psychiatric adverse events to perampanel… and to placebo?. Epilepsy & Behavior. 125. 108380–108380. 15 indexed citations
5.
Maguire, Melissa, Elinor Ben‐Menachem, Anna Patten, Manoj Malhotra, & Leock Y. Ngo. (2021). A post-approval observational study to evaluate the safety and tolerability of perampanel as an add-on therapy in adolescent, adult, and elderly patients with epilepsy. Epilepsy & Behavior. 126. 108483–108483. 11 indexed citations
6.
Wheless, James W., Robert Wechsler, Marcelo E. Lancman, et al.. (2020). Perampanel in real‐world clinical care of patients with epilepsy: Interim analysis of a phase IV study. Epilepsia Open. 6(1). 79–89. 10 indexed citations
7.
Rektor, Ivan, Gregory L. Krauss, Yushi Inoue, et al.. (2020). Assessment of the long‐term efficacy and safety of adjunctive perampanel in tonic‐clonic seizures: Analysis of four open‐label extension studies. Epilepsia. 61(7). 1491–1502. 15 indexed citations
8.
Piña-Garza, J. Eric, William E. Rosenfeld, Vicente Villanueva, et al.. (2020). Efficacy and safety of adjunctive perampanel in adolescent patients with epilepsy: Post hoc analysis of six randomized studies. Epilepsy & Behavior. 104(Pt A). 106876–106876. 28 indexed citations
9.
Brandt, Christian, Robert Wechsler, Terence J. O’Brien, et al.. (2020). Adjunctive perampanel and myoclonic and absence seizures: Post hoc analysis of data from study 332 in patients with idiopathic generalized epilepsy. Seizure. 80. 115–123. 19 indexed citations
11.
O'Brien, TJ, et al.. (2016). MYOCLONIC AND ABSENCE SEIZURES IN PATIENTS WITH IDIOPATHIC GENERALIZED EPILEPSY (IGE): EXPLORATORY OUTCOMES IN A PHASE III PGTC STUDY WITH ADJUNCTIVE PERAMPANEL. Epilepsia. 57. 1 indexed citations
14.
Patten, Anna, et al.. (2015). Prenatal ethanol exposure impairs temporal ordering behaviours in young adult rats. Behavioural Brain Research. 299. 81–89. 13 indexed citations
15.
16.
Yang, Haichen, Antonio Laurenza, Betsy Williams, et al.. (2015). Lack of effect of perampanel on QT interval duration: Results from a thorough QT analysis and pooled partial seizure Phase III clinical trials. Epilepsy Research. 114. 122–130. 15 indexed citations
17.
Cross, J. Helen, Stéphane Auvin, Anna Patten, & Luigi Giorgi. (2014). Safety and tolerability of zonisamide in paediatric patients with epilepsy. European Journal of Paediatric Neurology. 18(6). 747–758. 14 indexed citations
18.
Patten, Anna, et al.. (2013). Long-term exercise is needed to enhance synaptic plasticity in the hippocampus. Learning & Memory. 20(11). 642–647. 79 indexed citations
19.
Rascol, Olivier, Paolo Barone, Madhuri Behari, et al.. (2012). Perampanel in Parkinson Disease Fluctuations. Clinical Neuropharmacology. 35(1). 15–20. 45 indexed citations
20.
Patten, Anna, Patrícia S. Brocardo, & Brian R. Christie. (2012). Omega-3 supplementation can restore glutathione levels and prevent oxidative damage caused by prenatal ethanol exposure. The Journal of Nutritional Biochemistry. 24(5). 760–769. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026